NutriBand Inc. Logo

NutriBand Inc.

Develops abuse-deterrent transdermal patches to make potent drug delivery safer.

NTRB | US

Overview

Corporate Details

ISIN(s):
US67092M2089 (+1 more)
LEI:
Country:
United States of America
Address:
121 S. ORANGE AVE., 32801 ORLANDO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nutriband Inc. is a development-stage pharmaceutical company focused on creating transdermal drug delivery systems integrated with abuse-deterrent technology. The company's core platform is its proprietary AVERSA™ technology, designed to prevent the abuse, misuse, and accidental exposure of potent transdermal medications by incorporating aversive agents into the patch. Nutriband's lead product candidate is AVERSA™ Fentanyl, an abuse-deterrent fentanyl patch aimed at improving patient safety and addressing the opioid crisis. The company's mission is to enhance patient outcomes through innovative drug delivery platforms that combine therapeutic efficacy with safety measures against prescription drug abuse.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NutriBand Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NutriBand Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NutriBand Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
CorMedix Inc. Logo
Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.
United States of America CRMD
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Cosmos Health Inc. Logo
A global healthcare firm developing & distributing nutraceuticals, generics, and OTC medications.
United States of America COSM
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo
Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.
United States of America CELZ
CRESCENT BIOPHARMA, INC. Logo
A biotech company developing bispecific antibody therapies to treat solid tumors.
United States of America CBIO
Crinetics Pharmaceuticals, Inc. Logo
Develops novel therapeutics for rare endocrine diseases and related tumors.
United States of America CRNX
CRISPR Therapeutics AG Logo
Develops transformative CRISPR gene-based medicines for diseases like sickle cell.
United States of America CRSP

Talk to a Data Expert

Have a question? We'll get back to you promptly.